* Note: for reasons of patient confidentiality, it is not possible to identify MSImmigration officials held a cancer patient for four hours before they allowed him to enter the United States because one of its cancer drugs caused his fingerprints to disappear. His oncologist is now advising all patients with cancer who are treated with the commonly used drug, capecitabine, to carry a letter from your doctor if you want to go with them in the United States.
Dr Tan said that patients should capecitabine to bring a letter from your doctor with them. ‘My patient has traveled back with a letter from us, and had fewer problems getting through.’
Stott, MD, tells WebMD. Structures vaccine had a mortality rate of 14 percent during the winter, compared to 22 percent in the control sites. Influenza vaccine is not available for health care in the United Kingdom as regularly as they are in the United States, said Stott, professor of geriatric medicine at the University of Glasgow in Scotland.
Dr Tan concludes: ‘In summary, patients treated long-term capecitabine may have problems with regard to fingerprint identification when entering the ports or the United States ‘other countries require.’ Fingerprint Identification System and should be warned about it is uncertain when the onset of the loss of fingerprints will be sensitive in patients treated with capecitabine. However, it is possible that there is a growing of these patients as Mr. S that can benefit from capecitabine maintenance of malignancy circulated. These patients should prepare well before starting to avoid the inconvenience that Mr. S was passed
The incident has highlighted in a letter to the journal Cancer, Annals of Oncology. According to the oncologist, many cancer patients have reported loss of fingerprints on their blog sites, and some have also commented on similar problems entering the United States.
‘In December 2008, after more than three years of capecitabine, he went to the United States to visit his relatives,’ wrote Dr. Tan. It ‘was allowed to enter after the customs convinced that it was not a security threat. He was advised to travel with a letter from his doctor stating your condition and the treatment he was receiving to explain his lack of fingerprints to facilitate its entry in the future. ‘
Eng-Huat Dr. Tan, a senior consultant in the department of medical oncology at the National Cancer Centre, Singapore, described how his patient, a man of 62 years, had head and neck cancer that had spread , but had responded well to chemotherapy.
To help prevent the recurrence of the cancer patient was placed on a maintenance dose of capecitabine, an anti-metabolite.